Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 14 March 2008. doi:10.1136/bjsm.2007.042572
British Journal of Sports Medicine 2008;42:868-871
Copyright © 2008 BMJ Publishing Group Ltd & British Association of Sport and Exercise Medicine.

Original articles

Four weeks’ corticosteroid inhalation does not augment maximal power output in endurance athletes

H Kuipers1, G A C Van’t Hullenaar1, B M Pluim2, S E Overbeek3, O De Hon4, E J Van Breda1, L C Van Loon1

1 Department of Movement Sciences, Nutrition and Toxicology Research Institute Maastricht (NUTRIM), University of Maastricht, Maastricht, The Netherlands
2 KNLTB (Royal Dutch Lawn Tennis Federation), Amersfoort, The Netherlands
3 Department of Pulmonary Diseases, Bronovo Hospital, The Hague, The Netherlands
4 Anti-Doping Authority the Netherlands, Capelle a/d IJssel, The Netherlands

Harm Kuipers, FHML, Department of Movement Sciences, PO Box 616, 6200 MD Maastricht, The Netherlands; harm.kuipers{at}bw.unimaas.nl

Objective: To assess possible ergogenic properties of corticosteroid administration.

Design: A balanced, double-blind, placebo-controlled design was used.

Participants: 28 well-trained cyclists and rowers.

Intervention: 4 weeks’ daily inhalation of 800 µg budesonide or placebo.

Main outcome measurements: The subjects performed three incremental cycle ergometer tests until exhaustion, before and after 2 and 4 weeks of placebo or budesonide administration, to measure maximal power output (Wmax). Once a week they filled in a profile of mood state (POMS) questionnaire.

Results: There was no significant difference in Wmax between the placebo (376 (SD 25) W) and the corticosteroid group (375 (36) W) during the preintervention test, and there were no significant changes in either group after 2 and 4 weeks of intervention. No effect of the intervention on mood state was found.

Conclusion: 4 weeks of corticosteroid or placebo inhalation in healthy, well-trained athletes did not affect maximal power output or mood state. Hence no ergogenic properties of 4 weeks’ corticosteroid administration could be demonstrated, which corroborates previous studies of short-term corticosteroid administration.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

 

The journal is co-owned by and the official journal of BASEM

Official journal of ECOSEP

Available online to all members of ACSP, AMSSM and SMNZ